title: Authors' Reply to Gandjour "The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review".
authors.affiliation: Baxter Healthcare Corporation, Deerfield, IL, 60015, USA.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Laplante
authors.affiliation: Baxter Healthcare Corporation, Deerfield, IL, 60015, USA.
authors.forename: Frank X
authors.initials: FX
authors.lastname: Liu
authors.affiliation: Baxter Healthcare Corporation, Deerfield, IL, 60015, USA.
authors.forename: Bruce
authors.initials: B
authors.lastname: Culleton
authors.affiliation: Baxter Healthcare Corporation, Deerfield, IL, 60015, USA.
authors.forename: Angelito
authors.initials: A
authors.lastname: Bernardo
authors.affiliation: Abacus International, Bicester, UK. dking@dresourcesgroup.com.
authors.forename: Denise
authors.identifier: 0000-0002-4924-0748
authors.initials: D
authors.lastname: King
authors.affiliation: Abacus International, Bicester, UK.
authors.forename: Pollyanna
authors.initials: P
authors.lastname: Hudson
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D006435:Renal Dialysis